Literature DB >> 21498306

Mammographic morphology and distribution of calcifications in ductal carcinoma in situ diagnosed in organized screening.

Solveig Hofvind1, Barbro F Iversen, Liv Eriksen, Bodil M Styr, Kjell Kjellevold, Kathinka D Kurz.   

Abstract

BACKGROUND: Ductal carcinoma in situ of the breast (DCIS) represents a challenge in mammographic screening due to its unknown progression into invasive cancer. The majority of the DCIS is detected due to signs of calcifications on the mammograms.
PURPOSE: To analyze the combinations of mammographic morphology and distribution of calcifications by Van Nuys nuclear grade (grade).
MATERIAL AND METHODS: A total of 217 DCIS diagnosed in women aged 50-69 years old who participated in the Norwegian Breast Cancer Screening Program in the period November 1995 to December 2007 were reviewed by four breast imaging specialists. The mammograms were classified according to the morphology and distribution of the calcifications, using BI-RADS nomenclature. Chi square test was used to compare the groups of morphology and distribution by grade.
RESULTS: Calcifications were identified in 93% (202/217) of the cases, 15% (30/202) as grade 1 and 74% (149/202) as grade 3. Fine pleomorphic calcifications were seen in 38% (77/202) of the lesions and fine linear and fine linear branching in 31% (62/202). Sixty-nine percent (53/77) of the fine pleomorphic and 84% (52/62) of the fine linear and fine linear branching calcifications were high grade lesions. Grouped distribution was seen in about half of all the cases (104/202). Among the high grade lesions with fine pleomorphic or fine linear and fine linear branching calcifications, 75% (40/53) and 69% (36/52), respectively, had grouped or segmental distribution.
CONCLUSION: DCIS presented overlapping groups of morphology and distribution of calcification by grade, but fine pleomorphic and fine linear and fine linear branching calcifications with grouped and segmental distributions were associated with high grade DCIS. Seeking for further knowledge that allows separation of non-high grade from high grade DCIS has to continue to improve the quality of mammographic screening.

Entities:  

Mesh:

Year:  2011        PMID: 21498306     DOI: 10.1258/ar.2011.100357

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  16 in total

1.  Value of pre-operative breast MRI for the size assessment of ductal carcinoma in situ.

Authors:  Francesca Proulx; José A Correa; Romuald Ferré; Atilla Omeroglu; Ann Aldis; Sarkis Meterissian; Benoît Mesurolle
Journal:  Br J Radiol       Date:  2015-11-16       Impact factor: 3.039

2.  Breast tissue stiffness estimation for surgical guidance using gravity-induced excitation.

Authors:  Rebekah H Griesenauer; Jared A Weis; Lori R Arlinghaus; Ingrid M Meszoely; Michael I Miga
Journal:  Phys Med Biol       Date:  2017-05-18       Impact factor: 3.609

3.  US and MRI in the evaluation of mammographic BI-RADS 4 and 5 microcalcifications.

Authors:  Ana Hrkac Pustahija; Gordana Ivanac; Boris Brkljacic
Journal:  Diagn Interv Radiol       Date:  2018-07       Impact factor: 2.630

4.  Patient-calibrated agent-based modelling of ductal carcinoma in situ (DCIS): from microscopic measurements to macroscopic predictions of clinical progression.

Authors:  Paul Macklin; Mary E Edgerton; Alastair M Thompson; Vittorio Cristini
Journal:  J Theor Biol       Date:  2012-02-09       Impact factor: 2.691

5.  Hydroxyapatite mineral enhances malignant potential in a tissue-engineered model of ductal carcinoma in situ (DCIS).

Authors:  Frank He; Nora L Springer; Matthew A Whitman; Siddharth P Pathi; Yeonkyung Lee; Sunish Mohanan; Stephen Marcott; Aaron E Chiou; Bryant S Blank; Neil Iyengar; Patrick G Morris; Maxine Jochelson; Clifford A Hudis; Pragya Shah; Jennie A M R Kunitake; Lara A Estroff; Jan Lammerding; Claudia Fischbach
Journal:  Biomaterials       Date:  2019-09-11       Impact factor: 12.479

6.  Clinicopathologic, mammographic, and sonographic features in 1,187 patients with pure ductal carcinoma in situ of the breast by estrogen receptor status.

Authors:  Gaiane M Rauch; Henry M Kuerer; Marion E Scoggins; Patricia S Fox; Ana P Benveniste; Young Mi Park; Sara A Lari; Brian P Hobbs; Beatriz E Adrada; Savitri Krishnamurthy; Wei T Yang
Journal:  Breast Cancer Res Treat       Date:  2013-06-18       Impact factor: 4.872

7.  Microcalcifications in 1657 Patients with Pure Ductal Carcinoma in Situ of the Breast: Correlation with Clinical, Histopathologic, Biologic Features, and Local Recurrence.

Authors:  Gaiane M Rauch; Brian P Hobbs; Henry M Kuerer; Marion E Scoggins; Ana P Benveniste; Young Mi Park; Abigail S Caudle; Patricia S Fox; Benjamin D Smith; Beatriz E Adrada; Savitri Krishnamurthy; Wei T Yang
Journal:  Ann Surg Oncol       Date:  2015-09-28       Impact factor: 5.344

8.  Microcalcifications in breast cancer: novel insights into the molecular mechanism and functional consequence of mammary mineralisation.

Authors:  R F Cox; A Hernandez-Santana; S Ramdass; G McMahon; J H Harmey; M P Morgan
Journal:  Br J Cancer       Date:  2012-01-10       Impact factor: 7.640

9.  Osteomimicry of mammary adenocarcinoma cells in vitro; increased expression of bone matrix proteins and proliferation within a 3D collagen environment.

Authors:  Rachel F Cox; Allan Jenkinson; Kerstin Pohl; Fergal J O'Brien; Maria P Morgan
Journal:  PLoS One       Date:  2012-07-24       Impact factor: 3.240

10.  Oxalate induces breast cancer.

Authors:  Andrés M Castellaro; Alfredo Tonda; Hugo H Cejas; Héctor Ferreyra; Beatriz L Caputto; Oscar A Pucci; German A Gil
Journal:  BMC Cancer       Date:  2015-10-22       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.